Case Study: Vertex Pharmaceuticals achieves 50% lower cryo-EM data storage and processing costs with Amazon Web Services

Vertex Pharmaceuticals Reduces Costs of Cryo-EM Data Storage and Processing by 50% Using AWS

Vertex Pharmaceuticals needed to accelerate cryo-EM data storage and processing while reducing the high cost and bottlenecks of its on-premises environment. Using Amazon Web Services, the company moved workloads closer to its data in Amazon S3 and adopted AWS ParallelCluster to support elastic high-performance computing for analysis.

Amazon Web Services helped Vertex implement a scalable cloud architecture using Amazon S3, Amazon FSx for Lustre, Amazon EC2 G5 instances, and related services. As a result, Vertex cut storage and processing costs by 50%, achieved 2x better performance, and reduced cryo-EM analysis time from several weeks to under 1 week.

Vertex Pharmaceuticals

David Posson

Principal Research Scientist